Skip To Navigation Skip To Content Skip To Footer
    Advocacy Letter
    Home > Press Statements & Advocacy Letters > Advocacy Letters

    June 1, 2022 

    The Honorable Chiquita Brooks-LaSure Administrator
    Centers for Medicare and Medicaid Services
    Department of Health and Human Services
    7500 Security Boulevard
    Baltimore, MD 21244-1850

    Via Electronic Delivery

    Re: Step Therapy for Part B Drugs in Medicare Advantage

    Dear Administrator Brooks-LaSure,

    The undersigned organizations, representing millions of Medicare beneficiaries with life-threatening, complex, chronic conditions and/or the physicians who care for them, are asking the Centers for Medicare and Medicaid Services (CMS) to ensure that beneficiaries enrolled in Medicare Advantage plans continue to have appropriate and timely access to the therapies they need to properly manage their conditions. We are asking that the agency move swiftly to reinstate the step therapy prohibition in Medicare Advantage (MA) plans for Part B drugs as described in the September 17, 2012, HPMS memo Prohibition on Imposing Mandatory Step Therapy for Access to Part B Drugs and Services.


    View the full letter

    Explore Related Content

    More Advocacy Letters

    Explore Related Topics

    Ask MGMA
    Reload 🗙